MedPath

Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and MHealth Platform

Not Applicable
Conditions
Opioid Use Disorder
Interventions
Behavioral: AI driven CSDH-enhanced text only
Behavioral: PRC supported text + AI driven CSDH-enhanced text
Behavioral: Treatment as Usual (TAU)
Registration Number
NCT06573476
Lead Sponsor
Friends Research Institute, Inc.
Brief Summary

The study aims to adapt an existing Cultural Structural Humility (CSH) training into a video format for peer recovery coaches (PRCs) and refine an AI-driven texting tool to reinforce the training. After refining these tools using user-centered design, a pilot test will be conducted to assess their impact on the uptake of opioid treatment and social services. The study will also evaluate the feasibility and effectiveness of the intervention to inform future large-scale trials.

Detailed Description

The purpose of this study is to adapt an evidence-supported, currently staff-led Cultural Structural Humility (CSH) training to an interactive video format (7 brief video modules) for PRCs (Aim 1) while concurrently, refining a validated AI-driven texting tool that will newly reinforce core CSH training principles (Aim 2) that focus upon cultural and structural determinants of health (CSDH). After completing iterative refinement per user-centered design strategies based on the Technology Acceptance Model (TAM) for Aim 1 and 2, the investigators will pilot test CSH-trained PRCs delivering telephone based care/services coordination combined with refined AI-driven texting to enhance uptake of MOUD services, and social services (Aim 3). Aim 3 is sized for feasibility testing, final 'de-bugging' of the platform, and informing study conceptualization for a future large-scale efficacy trial. In this R34, the intervention effects will be assessed on the primary clinical outcome (i.e., receipt of buprenorphine), secondary outcome (i.e., uptake of social services), and implementation of the proposed multimodal intervention platform per the RE-AIM framework.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
180
Inclusion Criteria
  • ≥18 years of age
  • fluent in English
  • self-reported non-prescription opioid use <30 days prior to consent
  • provision of informed consent
  • planned stay in NYC ≥3 months
  • Black and/or Latinx race/ethnicity
  • positive urine toxicology for opioids per EMR records or study staff administered random saliva drug testing
  • diagnosis of OUD per the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
  • self-reported interest in initiating buprenorphine in primary care, or elsewhere.
Exclusion Criteria
  • inability to comprehend text content written at a 3rd grade reading level
  • physical or visual disability preventing mobile phone use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention Arm-2: AI driven CSDH-enhanced text onlyAI driven CSDH-enhanced text onlyIndividuals randomized to Arm-2 will receive the AI-driven CSDH-enhanced text messaging only
Intervention Arm-1: PRC supported text+ AI driven CSDH-enhanced textPRC supported text + AI driven CSDH-enhanced textIndividuals randomized to Arm-1 will receive PRC-supported text check-ins and AI-driven CSDH-enhanced text messaging.
Control Arm 3- Treatment as UsualTreatment as Usual (TAU)Individuals randomized to the control arm will receive treatment as usual.
Primary Outcome Measures
NameTimeMethod
Rate of AI-Driven Texting Use Among PWUO3 months

The frequency of AI-driven text interactions initiated by PWUO, captured through software logs.

Change in Felt and/or Anticipated Stigma3 months

The change in felt and/or anticipated stigma pre- and post-intervention, measured by a validated stigma assessment questionnaire.

The Amount of Self-Reported Social Services Use3 months

The self-reported utilization of social services at baseline, 1 month, and 3 months, addressing social determinants of health (SDH) to assess intervention effect sizes.

Estimated Rate of PRC-PWUO Contact3 months

The number of contacts between Peer Recovery Coaches (PRC) and People Who Use Opioids (PWUO), measured through communication logs.

Amount of time to Initial Receipt of Buprenorphine (Self-Reported)3 months

The time (in days) to the initial receipt of buprenorphine, as self-reported by participants.

Cost (Amount of Money) of Implementing and Sustaining the Multimodal Intervention3 months

The associated cost of implementing and sustaining the multimodal intervention, including cost-per quality-adjusted life year (QALY) and cost-per opioid use disorder (OUD) treatment days.

Secondary Outcome Measures
NameTimeMethod
The Amount of Participants That Retain in Treatment3 months

The number of participants continuously retained in buprenorphine treatment over a 12-week period, assessed at the 12-week mark.

Trial Locations

Locations (1)

START Treatment and Recovery

🇺🇸

New York City, New York, United States

© Copyright 2025. All Rights Reserved by MedPath